-
Post-antibiotic era is a worldwide challenge for health care: what to do ?
Asad U Khan
Letter to Editor: Clinical Investigation
-
Post-antibiotic era is a worldwide challenge for health care: what to do ?
Asad U Khan
Letter to Editor: Clinical Investigation
-
Post-antibiotic era is a worldwide challenge for health care: what to do ?
Asad U Khan
Letter to Editor: Clinical Investigation
-
Post-antibiotic era is a worldwide challenge for health care: what to do ?
Asad U Khan
Letter to Editor: Clinical Investigation
-
Post-antibiotic era is a worldwide challenge for health care: what to do ?
Asad U Khan
Letter to Editor: Clinical Investigation
-
Post-antibiotic era is a worldwide challenge for health care: what to do ?
Asad U Khan
Letter to Editor: Clinical Investigation
-
Post-antibiotic era is a worldwide challenge for health care: what to do ?
Asad U Khan
Letter to Editor: Clinical Investigation
-
Post-antibiotic era is a worldwide challenge for health care: what to do ?
Asad U Khan
Letter to Editor: Clinical Investigation
-
Corrigendum
Corrigendum: Clinical Investigation
-
Corrigendum
Corrigendum: Clinical Investigation
-
Corrigendum
Corrigendum: Clinical Investigation
-
Corrigendum
Corrigendum: Clinical Investigation
-
Corrigendum
Corrigendum: Clinical Investigation
-
Corrigendum
Corrigendum: Clinical Investigation
-
Corrigendum
Corrigendum: Clinical Investigation
-
Corrigendum
Corrigendum: Clinical Investigation
-
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?
Sarah Van de Velde
Editorial: Clinical Investigation
-
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?
Sarah Van de Velde
Editorial: Clinical Investigation
-
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?
Sarah Van de Velde
Editorial: Clinical Investigation
-
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?
Sarah Van de Velde
Editorial: Clinical Investigation
-
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?
Sarah Van de Velde
Editorial: Clinical Investigation
-
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?
Sarah Van de Velde
Editorial: Clinical Investigation
-
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?
Sarah Van de Velde
Editorial: Clinical Investigation
-
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?
Sarah Van de Velde
Editorial: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 3
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 3
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 3
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 3
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 3
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 3
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 3
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 3
Acknowledgements: Clinical Investigation
-
HIV Vaccine Trials Network: activities and achievements of the first decade and beyond
James G Kublin, Cecilia A Morgan, Tracey A Day, Peter B Gilbert, Steve G Self, M Juliana McElrath & Lawrence Corey
Research Update: Clinical Investigation
-
HIV Vaccine Trials Network: activities and achievements of the first decade and beyond
James G Kublin, Cecilia A Morgan, Tracey A Day, Peter B Gilbert, Steve G Self, M Juliana McElrath & Lawrence Corey
Research Update: Clinical Investigation
-
HIV Vaccine Trials Network: activities and achievements of the first decade and beyond
James G Kublin, Cecilia A Morgan, Tracey A Day, Peter B Gilbert, Steve G Self, M Juliana McElrath & Lawrence Corey
Research Update: Clinical Investigation
-
HIV Vaccine Trials Network: activities and achievements of the first decade and beyond
James G Kublin, Cecilia A Morgan, Tracey A Day, Peter B Gilbert, Steve G Self, M Juliana McElrath & Lawrence Corey
Research Update: Clinical Investigation
-
HIV Vaccine Trials Network: activities and achievements of the first decade and beyond
James G Kublin, Cecilia A Morgan, Tracey A Day, Peter B Gilbert, Steve G Self, M Juliana McElrath & Lawrence Corey
Research Update: Clinical Investigation
-
HIV Vaccine Trials Network: activities and achievements of the first decade and beyond
James G Kublin, Cecilia A Morgan, Tracey A Day, Peter B Gilbert, Steve G Self, M Juliana McElrath & Lawrence Corey
Research Update: Clinical Investigation
-
HIV Vaccine Trials Network: activities and achievements of the first decade and beyond
James G Kublin, Cecilia A Morgan, Tracey A Day, Peter B Gilbert, Steve G Self, M Juliana McElrath & Lawrence Corey
Research Update: Clinical Investigation
-
HIV Vaccine Trials Network: activities and achievements of the first decade and beyond
James G Kublin, Cecilia A Morgan, Tracey A Day, Peter B Gilbert, Steve G Self, M Juliana McElrath & Lawrence Corey
Research Update: Clinical Investigation
-
Anti-MET Targeted therapy for NSCLC: has it come of age?
Patrick C Ma
Editorial: Clinical Investigation
-
Anti-MET Targeted therapy for NSCLC: has it come of age?
Patrick C Ma
Editorial: Clinical Investigation
-
Anti-MET Targeted therapy for NSCLC: has it come of age?
Patrick C Ma
Editorial: Clinical Investigation
-
Anti-MET Targeted therapy for NSCLC: has it come of age?
Patrick C Ma
Editorial: Clinical Investigation
-
Anti-MET Targeted therapy for NSCLC: has it come of age?
Patrick C Ma
Editorial: Clinical Investigation
-
Anti-MET Targeted therapy for NSCLC: has it come of age?
Patrick C Ma
Editorial: Clinical Investigation
-
Anti-MET Targeted therapy for NSCLC: has it come of age?
Patrick C Ma
Editorial: Clinical Investigation
-
Anti-MET Targeted therapy for NSCLC: has it come of age?
Patrick C Ma
Editorial: Clinical Investigation
-
Overcoming VEGF resistance in renal cancer. biologic and therapeutic implications
Sarmad Sadeghi, Jorge A Garcia
Review: Clinical Trail Outcomes: Clinical Investigation
-
Overcoming VEGF resistance in renal cancer. biologic and therapeutic implications
Sarmad Sadeghi, Jorge A Garcia
Review: Clinical Trail Outcomes: Clinical Investigation
-
Overcoming VEGF resistance in renal cancer. biologic and therapeutic implications
Sarmad Sadeghi, Jorge A Garcia
Review: Clinical Trail Outcomes: Clinical Investigation
-
Overcoming VEGF resistance in renal cancer. biologic and therapeutic implications
Sarmad Sadeghi, Jorge A Garcia
Review: Clinical Trail Outcomes: Clinical Investigation
-
Overcoming VEGF resistance in renal cancer. biologic and therapeutic implications
Sarmad Sadeghi, Jorge A Garcia
Review: Clinical Trail Outcomes: Clinical Investigation
-
Overcoming VEGF resistance in renal cancer. biologic and therapeutic implications
Sarmad Sadeghi, Jorge A Garcia
Review: Clinical Trail Outcomes: Clinical Investigation
-
Overcoming VEGF resistance in renal cancer. biologic and therapeutic implications
Sarmad Sadeghi, Jorge A Garcia
Review: Clinical Trail Outcomes: Clinical Investigation
-
Overcoming VEGF resistance in renal cancer. biologic and therapeutic implications
Sarmad Sadeghi, Jorge A Garcia
Review: Clinical Trail Outcomes: Clinical Investigation
-
Developing support for mental health clinical research: the National Institute for Health Research Mental Health Research Network (MHRN) experience
Patrick Callaghan, Anthony David, Shon Lewis, Max Marshall, George Szmukler, Til Wykes, Joanne Ashcroft, Stephanie Burns
Research Update: Clinical Investigation
-
Developing support for mental health clinical research: the National Institute for Health Research Mental Health Research Network (MHRN) experience
Patrick Callaghan, Anthony David, Shon Lewis, Max Marshall, George Szmukler, Til Wykes, Joanne Ashcroft, Stephanie Burns
Research Update: Clinical Investigation
-
Developing support for mental health clinical research: the National Institute for Health Research Mental Health Research Network (MHRN) experience
Patrick Callaghan, Anthony David, Shon Lewis, Max Marshall, George Szmukler, Til Wykes, Joanne Ashcroft, Stephanie Burns
Research Update: Clinical Investigation
-
Developing support for mental health clinical research: the National Institute for Health Research Mental Health Research Network (MHRN) experience
Patrick Callaghan, Anthony David, Shon Lewis, Max Marshall, George Szmukler, Til Wykes, Joanne Ashcroft, Stephanie Burns
Research Update: Clinical Investigation
-
Developing support for mental health clinical research: the National Institute for Health Research Mental Health Research Network (MHRN) experience
Patrick Callaghan, Anthony David, Shon Lewis, Max Marshall, George Szmukler, Til Wykes, Joanne Ashcroft, Stephanie Burns
Research Update: Clinical Investigation
-
Developing support for mental health clinical research: the National Institute for Health Research Mental Health Research Network (MHRN) experience
Patrick Callaghan, Anthony David, Shon Lewis, Max Marshall, George Szmukler, Til Wykes, Joanne Ashcroft, Stephanie Burns
Research Update: Clinical Investigation
-
Developing support for mental health clinical research: the National Institute for Health Research Mental Health Research Network (MHRN) experience
Patrick Callaghan, Anthony David, Shon Lewis, Max Marshall, George Szmukler, Til Wykes, Joanne Ashcroft, Stephanie Burns
Research Update: Clinical Investigation
-
Developing support for mental health clinical research: the National Institute for Health Research Mental Health Research Network (MHRN) experience
Patrick Callaghan, Anthony David, Shon Lewis, Max Marshall, George Szmukler, Til Wykes, Joanne Ashcroft, Stephanie Burns
Research Update: Clinical Investigation
-
Statistical design and analysis issues for the ARDS clinical trials network: the Coordinating Center perspective
David Schoenfeld
Clinical Trail Perspective: Clinical Investigation
-
Statistical design and analysis issues for the ARDS clinical trials network: the Coordinating Center perspective
David Schoenfeld
Clinical Trail Perspective: Clinical Investigation
-
Statistical design and analysis issues for the ARDS clinical trials network: the Coordinating Center perspective
David Schoenfeld
Clinical Trail Perspective: Clinical Investigation
-
Statistical design and analysis issues for the ARDS clinical trials network: the Coordinating Center perspective
David Schoenfeld
Clinical Trail Perspective: Clinical Investigation
-
Statistical design and analysis issues for the ARDS clinical trials network: the Coordinating Center perspective
David Schoenfeld
Clinical Trail Perspective: Clinical Investigation
-
Statistical design and analysis issues for the ARDS clinical trials network: the Coordinating Center perspective
David Schoenfeld
Clinical Trail Perspective: Clinical Investigation
-
Statistical design and analysis issues for the ARDS clinical trials network: the Coordinating Center perspective
David Schoenfeld
Clinical Trail Perspective: Clinical Investigation
-
Statistical design and analysis issues for the ARDS clinical trials network: the Coordinating Center perspective
David Schoenfeld
Clinical Trail Perspective: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Ulipristal acetate (ellaOne) for emergency contraception: review of the clinical evidence
Kristina Gemzell-Danielsson,Sharon T Cameron
Review Article: Clinical Investigation
-
Ulipristal acetate (ellaOne) for emergency contraception: review of the clinical evidence
Kristina Gemzell-Danielsson,Sharon T Cameron
Review Article: Clinical Investigation
-
Ulipristal acetate (ellaOne) for emergency contraception: review of the clinical evidence
Kristina Gemzell-Danielsson,Sharon T Cameron
Review Article: Clinical Investigation
-
Ulipristal acetate (ellaOne) for emergency contraception: review of the clinical evidence
Kristina Gemzell-Danielsson,Sharon T Cameron
Review Article: Clinical Investigation
-
Ulipristal acetate (ellaOne) for emergency contraception: review of the clinical evidence
Kristina Gemzell-Danielsson,Sharon T Cameron
Review Article: Clinical Investigation
-
Ulipristal acetate (ellaOne) for emergency contraception: review of the clinical evidence
Kristina Gemzell-Danielsson,Sharon T Cameron
Review Article: Clinical Investigation
-
Ulipristal acetate (ellaOne) for emergency contraception: review of the clinical evidence
Kristina Gemzell-Danielsson,Sharon T Cameron
Review Article: Clinical Investigation
-
Ulipristal acetate (ellaOne) for emergency contraception: review of the clinical evidence
Kristina Gemzell-Danielsson,Sharon T Cameron
Review Article: Clinical Investigation